Viking Therapeutics (VKTX) Misses Q2 EPS by 13c

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Dell’s earning report was bullish for Intel CPU demand, analyst says
• Blue Owl Is Said To Plan Public Company For Data Center Roll-up - Bloomberg
• Micron Technology (MU) call put ratio 1.9 calls to 1 put amid share price up 4.5%